OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
Yuji Kitaichi, Takeshi Inoue, Nobuyuki Mitsui, et al.
Neuropsychiatric Disease and Treatment (2013), pp. 1591-1591
Open Access | Times Cited: 17
Yuji Kitaichi, Takeshi Inoue, Nobuyuki Mitsui, et al.
Neuropsychiatric Disease and Treatment (2013), pp. 1591-1591
Open Access | Times Cited: 17
Showing 17 citing articles:
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia
Dawn Matthews, Aaron Ritter, Ronald G. Thomas, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Dawn Matthews, Aaron Ritter, Ronald G. Thomas, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Potential roles for opioid receptors in motivation and major depressive disorder
Charlotte K. Callaghan, Jennifer Rouine, Shane M. O’Mara
Progress in brain research (2018), pp. 89-119
Closed Access | Times Cited: 33
Charlotte K. Callaghan, Jennifer Rouine, Shane M. O’Mara
Progress in brain research (2018), pp. 89-119
Closed Access | Times Cited: 33
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
Stephanie Matt, Peter J. Gaskill
Brain Research (2019) Vol. 1723, pp. 146398-146398
Open Access | Times Cited: 26
Stephanie Matt, Peter J. Gaskill
Brain Research (2019) Vol. 1723, pp. 146398-146398
Open Access | Times Cited: 26
Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity
Toshiko Ishikawa, Motoki Okano, Akiko Minami, et al.
Behavioural Brain Research (2018) Vol. 359, pp. 353-361
Open Access | Times Cited: 25
Toshiko Ishikawa, Motoki Okano, Akiko Minami, et al.
Behavioural Brain Research (2018) Vol. 359, pp. 353-361
Open Access | Times Cited: 25
Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions
Hector M Contreras-Mora, Margaret Rowland, Samantha E. Yohn, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 166, pp. 13-20
Closed Access | Times Cited: 10
Hector M Contreras-Mora, Margaret Rowland, Samantha E. Yohn, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 166, pp. 13-20
Closed Access | Times Cited: 10
Preclinical Herb–Drug Pharmacokinetic Interaction of Panax ginseng Extract and Selegiline in Freely Moving Rats
Ling Yang, Chi-Lin Li, Tung‐Hu Tsai
ACS Omega (2020) Vol. 5, Iss. 9, pp. 4682-4688
Open Access | Times Cited: 9
Ling Yang, Chi-Lin Li, Tung‐Hu Tsai
ACS Omega (2020) Vol. 5, Iss. 9, pp. 4682-4688
Open Access | Times Cited: 9
A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult
Amie Taggart Blaszczyk, Monica Mathys, Jennifer Lê
Drugs & Aging (2023) Vol. 40, Iss. 9, pp. 785-813
Closed Access | Times Cited: 3
Amie Taggart Blaszczyk, Monica Mathys, Jennifer Lê
Drugs & Aging (2023) Vol. 40, Iss. 9, pp. 785-813
Closed Access | Times Cited: 3
Beneficial effects of physical activity on depressive and OCD-like behaviors in the male offspring of morphine-abstinent rats
Setareh Nouri Zadeh‐Tehrani, Mitra‐Sadat Sadat‐Shirazi, Ardeshir Akbarabadi, et al.
Brain Research (2020) Vol. 1744, pp. 146908-146908
Closed Access | Times Cited: 8
Setareh Nouri Zadeh‐Tehrani, Mitra‐Sadat Sadat‐Shirazi, Ardeshir Akbarabadi, et al.
Brain Research (2020) Vol. 1744, pp. 146908-146908
Closed Access | Times Cited: 8
Pramipexole and Selegiline Combination Therapy in a Case of Treatment-Resistant Depression
Rémi Moirand, Filipe Galvão, Clément Dondé
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 6, pp. 684-685
Closed Access | Times Cited: 7
Rémi Moirand, Filipe Galvão, Clément Dondé
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 6, pp. 684-685
Closed Access | Times Cited: 7
ROLE OF ENZYMES IN THE PATHOGENESIS OF DEPRESSION
Vaibhav Walia
Journal of Critical Reviews (2016) Vol. 3, Iss. 2, pp. 11-16
Closed Access | Times Cited: 5
Vaibhav Walia
Journal of Critical Reviews (2016) Vol. 3, Iss. 2, pp. 11-16
Closed Access | Times Cited: 5
Selegiline Modulates Lipid Metabolism by Activating AMPK Pathways of Epididymal White Adipose Tissues in HFD-Fed Obese Mice
Hye-Young Joung, Jung-Mi Oh, Min‐Suk Song, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2539-2539
Open Access | Times Cited: 2
Hye-Young Joung, Jung-Mi Oh, Min‐Suk Song, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2539-2539
Open Access | Times Cited: 2
Development and Evaluation of Thermo Triggered in situ Nasal Gel of Selegiline for Depressive Disorders: In vitro, in vivo and ex vivo Characterization
Shiv Kumar Srivastava, Mahesh Prasad, Antesh Kumar Jha
Research Journal of Pharmacy and Technology (2022), pp. 1424-1430
Closed Access | Times Cited: 4
Shiv Kumar Srivastava, Mahesh Prasad, Antesh Kumar Jha
Research Journal of Pharmacy and Technology (2022), pp. 1424-1430
Closed Access | Times Cited: 4
The role of nitric oxide–cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test
Sattar Ostadhadi, Saeed Shakiba, Abbas Norouzi‐Javidan, et al.
Pharmacological Reports (2018) Vol. 70, Iss. 5, pp. 1015-1022
Closed Access | Times Cited: 4
Sattar Ostadhadi, Saeed Shakiba, Abbas Norouzi‐Javidan, et al.
Pharmacological Reports (2018) Vol. 70, Iss. 5, pp. 1015-1022
Closed Access | Times Cited: 4
The art of suicidal molecular seduction for targeting drug resistance
Mohammad Hassan Moshafi, Saeid Ghasemshirazi, Ardavan Abiri
Medical Hypotheses (2020) Vol. 140, pp. 109676-109676
Closed Access | Times Cited: 1
Mohammad Hassan Moshafi, Saeid Ghasemshirazi, Ardavan Abiri
Medical Hypotheses (2020) Vol. 140, pp. 109676-109676
Closed Access | Times Cited: 1
The effects of rasagiline on cerebral glucose metabolism, cognition, and tau in a double-blind, placebo-controlled Phase II clinical trial in Alzheimer’s dementia
Dawn C. Matthews, Aaron Ritter, Ronald G. Thomas, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Dawn C. Matthews, Aaron Ritter, Ronald G. Thomas, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
